Form 4 Tracker
Arcutis Biotherapeutics, Inc.
ARQT

32 insider filings · Latest: Jun 15, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Feb 2, 2026Feb 5 12:25 AMTodd WatanabeDirector, Reporting Person's title: President and Chief Executive Officer
Sale
19,833$25.50$505.7K721,306(D)

View →

Feb 2, 2026Feb 5 12:24 AMLatha VairavanSVP Chief Financial Officer
Sale
1,320$25.50$33.7K63,607(D)

View →

Feb 2, 2026Feb 5 12:23 AMHoward G. WelgusDirector
Sale
10,000$25.05$250.5K59,744(D)

View →

Feb 2, 2026Feb 5 12:21 AMLarry Todd EdwardsReporting Person's title: EVP Chief Commercial Officer
Sale
2,052$25.50$52.3K148,865(D)

View →

Feb 4, 2026Feb 4 9:52 PMPatrick Burnett
Proposed Sale
9,794$25.81$252.7K

View →

Feb 2, 2026Feb 2 11:19 PMMasaru Matsuda
Proposed Sale
40,638$25.28$1.0M

View →

Feb 2, 2026Feb 2 11:17 PMTodd Edwards
Proposed Sale
2,052$25.50$52.3K

View →

Feb 2, 2026Feb 2 11:15 PMLatha Vairavan
Proposed Sale
1,320$25.50$33.7K

View →

Feb 2, 2026Feb 2 10:48 PMPatrick Burnett
Proposed Sale
3,675$25.50$93.7K

View →

Feb 2, 2026Feb 2 10:41 PMTodd Frank Watanabe
Proposed Sale
19,833$25.50$505.7K

View →

Feb 2, 2026Feb 2 10:04 PMHoward Welgus
Proposed Sale
10,000$25.05$250.5K

View →

Jan 5, 2026Jan 5 9:01 PMPatrick Burnett
Proposed Sale
2,490$28.98$72.2K

View →

Jan 2, 2026Jan 2 9:00 PMHoward Welgus
Proposed Sale
10,000$28.96$289.6K

View →

Dec 31, 2025Dec 31 9:01 PMPatrick Burnett
Proposed Sale
1,697$29.21$49.6K

View →

Dec 15, 2025Dec 15 9:07 PMPatrick Burnett
Proposed Sale
11,500$28.94$332.9K

View →

Dec 1, 2025Dec 1 9:07 PMHoward Welgus
Proposed Sale
10,000$30.21$302.1K

View →

Dec 1, 2025Dec 1 9:06 PMMasaru Matsuda
Proposed Sale
1,657$30.23$50.1K

View →

Nov 24, 2025Nov 24 9:01 PMSue-Jean Lin
Proposed Sale
25,272$30.78$778.0K

View →

Nov 24, 2025Nov 24 8:55 PMTodd Franklin Watanabe
Proposed Sale
48,945$30.36$1.5M

View →

Nov 21, 2025Nov 21 9:49 PMTodd Franklin Watanabe
Proposed Sale
1,055$30.00$31.6K

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jun 15, 2026Jun 18 12:40 AMHoward G. WelgusDirector
Option Exercise
4,096$8.6324,797(D)

View →

Jun 5, 2026Jun 10 1:21 AMPatrick J HeronDirector
Grant/Award
16,667$21.2316,667(D)

View →

Jun 5, 2026Jun 10 1:21 AMSue-Jean LinDirector
Grant/Award
16,667$21.2316,667(D)

View →

Jun 5, 2026Jun 10 1:21 AMHoward G. WelgusDirector
Grant/Award
16,667$21.2316,667(D)

View →

Jun 5, 2026Jun 10 1:21 AMKeith R LeonardDirector
Grant/Award
16,667$21.2316,667(D)

View →

Jun 5, 2026Jun 10 1:21 AMTerrie CurranDirector
Grant/Award
16,667$21.2316,667(D)

View →

Jun 5, 2026Jun 10 1:21 AMAmit MunshiDirector
Grant/Award
16,667$21.2316,667(D)

View →

Jun 5, 2026Jun 10 1:20 AMHalley E GilbertDirector
Grant/Award
16,667$21.2316,667(D)

View →

Jun 5, 2026Jun 10 1:20 AMNeha KrishnamohanDirector
Grant/Award
16,667$21.2316,667(D)

View →

Mar 2, 2026Mar 4 9:17 PMKeith R LeonardDirector
Option Exercise
39,272$8.630(D)

View →

Feb 27, 2026Mar 4 1:43 AMLarry Todd EdwardsReporting Person's title: EVP, Chief Commercial Officer
Grant/Award
77,000$26.9777,000(D)

View →

Feb 27, 2026Mar 4 1:42 AMTodd WatanabeDirector, Reporting Person's title: President and Chief Executive Officer
Grant/Award
266,000$26.97266,000(D)

View →

Feb 27, 2026Mar 4 1:42 AMMasaru MatsudaReporting Person's title: EVP, Chief Legal Officer
Grant/Award
97,000$26.9797,000(D)

View →

Feb 27, 2026Mar 4 1:42 AMLatha VairavanSVP Chief Financial Officer
Grant/Award
70,000$26.9770,000(D)

View →

Feb 27, 2026Mar 4 1:41 AMPatrick BurnettReporting Person's title: EVP, Chief Medical Officer
Grant/Award
77,000$26.9777,000(D)

View →